New Directions in the Diagnosis and Treatment of Hematologic Cancers: Highlights from International Medical Meetings

ash_header

Hematologic malignancies research is growing at a rapid pace, increasing the complexity of the field. Advances in the understanding of the mechanisms of hematologic malignancies have resulted in the development of new prognostic models, novel therapies, and improvements in disease management. It is essential to our community to stay abreast of the latest findings in the field and of their potential impaact on clinical practices.

This symposium will provide attendees with cutting-edge updates and perspectives on new diagnostic tools and management options of hematologic malignancies including genetic profiling, cytogenetics, molecular diagnostics, riskadaptive strategies, and novel therapies recently approved by the FDA. Advances in the understanding of aggressive/ indolent lymphoma, myelodysplasia, plasma cell dyscrasia, acute/chronic leukemia and myeloproliferative disease, will be addressed. Advances in newer therapeutic approaches in classical hematology will be reviewed in the Consultative Hematology section.

View Agenda

COMPLIMENTARY REGISTRATION

Registration Deadline: Monday, April 10, 2023

Register for this activity

Details

VIRTUAL CME:Tuesday, April 11, 2023

5:00–9:30 pm EDT Exhibit Hall Open

6:00–8:50 pm EDT Education Program

8:50–9:20 pm EDT Virtual Q&A Reception & Exhibit Hall

Download Flyer

Intended Audience

The program is designed for oncologists, hematologists, radiation oncologists, pathologists, internists, primary care physicians, fellows, physician assistants, nurse practitioners, oncology nurses, and social workers.

Inquiries

Lucía Tono, PhD, Med: 215-728-3797
Lucia.Tono-Ramirez@tuhs.temple.edu

Presenters

Program Director

Rashmi Khanal, MD
Assistant Professor, Department of Bone Marrow Transplant and Cellular Therapies

Faculty

Henry Fung, MD, FACP, FRCPE
Chair and Professor, Department of Bone Marrow Transplant and Cellular Therapies

Peter Abdelmessieh, DO, MSc
Assistant Professor, Department of Bone Marrow Transplant and Cellular Therapies

Iberia Romina Sosa, MD, PhD
Associate Professor, Department of Hematology/Oncology

Shazia Nakhoda, MD
Assistant Professor, Department of Hematology/Oncology

Asya Varshavsky-Yanovsky, MD, PhD
Assistant Professor, Department of Bone Marrow Transplant and Cellular Therapies

Marcus Messmer, MD
Assistant Professor, Department of Hematology/Oncology

Michael Styler, MD
Associate Professor, Department of Bone Marrow Transplant and Cellular Therapies

Learning Objectives

After participating in this educational program, learners should be able to:

  • Summarize the findings from key clinical trials presented at the 2022 ASH meeting that will impact standards of care in hematology
  • Discuss the latest findings in genetic profiling, cytogenetics, and molecular biology, and describe how this information can be utilized in determining patient prognosis and treatment course
  • List novel, targeted therapies in development for hematology and explain the therapeutic rationale for these agents
  • Describe the latest advances in the field of Consultative Hematology that will impact patient treatment
  • Outline how clinical trial data can be efficiently incorporated into community-based hematology practice

Accreditation Statement

The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.

Designation Statement

The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity.

  Register for this activity

Published

March 6, 2023

Expires

March 6, 2023

Related Presenters

Rashmi Khanal, MD

Rashmi Khanal, MD

Assistant Professor, Department of Bone Marrow Transplant and Cellular Therapies

Henry Fung, MD, FACP, FRCPE

Henry Fung, MD, FACP, FRCPE

Chair and Professor, Department of Bone Marrow Transplant and Cellular Therapies

Peter Abdelmessieh, DO, MSc

Peter Abdelmessieh, DO, MSc

Assistant Professor, Department of Bone Marrow Transplant and Cellular Therapies

Iberia Romina Sosa, MD, PhD

Iberia Romina Sosa, MD, PhD

Associate Professor, Department of Hematology/Oncology

Shazia Nakhoda, MD

Shazia Nakhoda, MD

Assistant Professor, Department of Hematology/Oncology, Hematology-Lymphoma Program

Asya Varshavsky-Yanovsky, MD, PhD

Asya Varshavsky-Yanovsky, MD, PhD

Assistant Professor, Department of Bone Marrow Transplant and Cellular Therapies

Marcus Messmer, MD

Marcus Messmer, MD

Assistant Professor, Department of Hematology/Oncology

Michael Styler, MD

Michael Styler, MD

Associate Professor, Department of Bone Marrow Transplant and Cellular Therapies